Inovio Pharmaceuticals, Inc. (INO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.19+0.04 (+0.44%)
At close: 4:00PM EST
9.25 +0.06 (0.65%)
After hours: 6:29PM EST
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
7,411
7,411
4,112
30,482
42,220
Operating expenses
Research development
94,245
94,245
88,017
95,258
98,573
Selling general and administrative
37,248
37,248
27,203
29,315
28,290
Total operating expenses
131,493
131,493
115,220
124,573
126,863
Operating income or loss
-124,082
-124,082
-111,109
-94,091
-84,643
Interest expense
8,702
8,702
7,949
-
-
Total other income/expenses net
-33,418
-33,418
-4,358
-1,628
-5,176
Income before tax
-162,890
-162,890
-120,809
-94,798
-88,206
Income tax expense
0
0
-257.335
2,170
-
Income from continuing operations
-167,475
-167,475
-120,552
-96,968
-88,206
Net income
-166,411
-166,411
-119,359
-96,968
-88,206
Net income available to common shareholders
-166,411
-166,411
-119,359
-96,968
-88,206
Basic EPS
-
-1.07
-1.21
-1.05
-1.08
Diluted EPS
-
-1.07
-1.21
-1.05
-1.09
Basic average shares
-
155,127
98,718
92,540
81,777
Diluted average shares
-
155,127
98,718
92,540
81,918
EBITDA
-
-149,560
-107,344
-89,094
-81,174
© 2021 Verizon Media. All rights reserved.
